Related references
Note: Only part of the references are listed.TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice
Varsha Shukla et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease
Lana M. Osborn et al.
PROGRESS IN NEUROBIOLOGY (2016)
Reactive Astrogliosis: Role in Alzheimer's Disease
Priti Jain et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations
Pragati P. Nahar et al.
JOURNAL OF MEDICINAL FOOD (2015)
Nanotechnology-Applied Curcumin for Different Diseases Therapy
Negar Ghalandarlaki et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Innate immune activation in neurodegenerative disease
Michael T. Heneka et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Curcumin as a Potential Treatment for Alzheimer's Disease: A Study of the Effects of Curcumin on Hippocampal Expression of Glial Fibrillary Acidic Protein
Yunliang Wang et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2013)
Curcumin and neurodegenerative diseases
Adriana Monroy et al.
BIOFACTORS (2013)
A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice
Varsha Shukla et al.
FASEB JOURNAL (2013)
Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice
Qiu-Lan Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Specific Inhibition of p25/Cdk5 Activity by the Cdk5 Inhibitory Peptide Reduces Neurodegeneration In Vivo
Jeyapriya Raja Sundaram et al.
JOURNAL OF NEUROSCIENCE (2013)
Evaluation in Vitro of Synthetic Curcumins As Agents Promoting Monocytic Gene Expression Related to β-Amyloid Clearance
S. Gagiardi et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Optimized Turmeric Extract Reduces β-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer's Transgenic Mice
R. Douglas Shytle et al.
CURRENT ALZHEIMER RESEARCH (2012)
Anti-inflammatory effects of aromatic-turmerone through blocking of NF-κB, JNK, and p38 MAPK signaling pathways in amyloid β-stimulated microglia
Sun Young Park et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Cdk5/p25-Induced Cytosolic PLA2-Mediated Lysophosphatidylcholine Production Regulates Neuroinflammation and Triggers Neurodegeneration
Jeyapriya R. Sundaram et al.
JOURNAL OF NEUROSCIENCE (2012)
Curcumins Promote Monocytic Gene Expression Related to β-Amyloid and Superoxide Dismutase Clearance
J. R. Cashman et al.
NEURODEGENERATIVE DISEASES (2012)
Safety assessment of a solid lipid curcumin particle preparation: Acute and subchronic toxicity studies
Paresh Dadhaniya et al.
FOOD AND CHEMICAL TOXICOLOGY (2011)
Safety and Pharmacokinetics of a Solid Lipid Curcumin Particle Formulation in Osteosarcoma Patients and Healthy Volunteers
Vikram S. Gota et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
PPAR gamma Agonist Curcumin Reduces the Amyloid-beta-Stimulated Inflammatory Responses in Primary Astrocytes
Hong-Mei Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Curcumin Decreases Amyloid-β Peptide Levels by Attenuating the Maturation of Amyloid-β Precursor Protein
Can Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cdk5-Mediated Phosphorylation of δ-Catenin Regulates Its Localization and GluR2-Mediated Synaptic Activity
Charlene P. Poore et al.
JOURNAL OF NEUROSCIENCE (2010)
Does neuroinflammation fan the flame in neurodegenerative diseases?
Tamy C. Frank-Cannon et al.
MOLECULAR NEURODEGENERATION (2009)
Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice - A model for hippocampal sclerosis and neocortical degeneration
David Muyllaert et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
The effect of curcumin (turmeric) on Alzheimer's disease: An overview
Shrikant Mishra et al.
ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2008)
Immune defects in Alzheimer's disease: new medications development
John R. Cashman et al.
BMC NEUROSCIENCE (2008)
Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease
Aynun N. Begum et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Bioavailability of curcumin: Problems and promises
Preetha Anand et al.
MOLECULAR PHARMACEUTICS (2007)
Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model
M. Garcia-Alloza et al.
JOURNAL OF NEUROCHEMISTRY (2007)
P25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid β in vivo
Jonathan C. Cruz et al.
JOURNAL OF NEUROSCIENCE (2006)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
The Arctic Alzheimer mutation facilitates early intraneuronal A beta aggregation and senile plaque formation in transgenic mice
A Lord et al.
NEUROBIOLOGY OF AGING (2006)
Microglial phagocytosis induced by fibrillar β-amyloid and IgGs are differentially regulated by proinflammatory cytokines
J Koenigsknecht-Talboo et al.
JOURNAL OF NEUROSCIENCE (2005)
Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice
LM Billings et al.
NEURON (2005)
Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo
FS Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide
S Kesavapany et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
Cdk5 deregulation in the pathogenesis of Alzheimer's disease
JC Cruz et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease
PD Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles
JC Cruz et al.
NEURON (2003)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
Early intraneuronal Aβ deposition in the hippocampus of APP transgenic mice
FS Shie et al.
NEUROREPORT (2003)
Curcumin suppresses janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia
HY Kim et al.
JOURNAL OF IMMUNOLOGY (2003)
Cyclin-dependent kinase 5 in amyotrophic lateral sclerosis
MD Nguyen et al.
NEUROSIGNALS (2003)
Cdk5 as a drug target for the treatment of Alzheimer's disease
LF Lau et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2002)
Comparative analysis of an improved thioflavin-S stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections
AY Sun et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology
SA Frautschy et al.
NEUROBIOLOGY OF AGING (2001)
Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice
O Wirths et al.
NEUROSCIENCE LETTERS (2001)
TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
T Wyss-Coray et al.
NATURE MEDICINE (2001)
Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25
G Kusakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Neurotoxicity induces cleavage of p35 to p25 by calpain
MS Lee et al.
NATURE (2000)
Share Paper
